Algo version: 0.98b
Biogen Inc is listed at the LSE Exchange
Biogen Inc [0R1B.L]
LSE Sector: Healthcare Industry:Medical Pharmaceuticals

Is Biogen Inc stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Biogen Inc pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Tuesday 15th of March 2022 were paid $0.285 per share. Over the last 1 times between 2022 and 2022, Biogen Inc has paid $0.285 with an average of $0.29 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Biogen Inc 10 years ago, but if you had invested on Friday 6th of August 2021 when the price was $342.03, you would have made a loss of $-186.09 per share or -54.41%

We do not have enough data to give you this answer.

Biogen Inc has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.34, the company's ability to pay off the debt is normal. Biogen Inc has a good net profit margin of 17.17% and should have high tolerances against inflation.

We have calculated the inflation risk for Biogen Inc to be low [0.4 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.